Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors

Human Psychopharmacology

Volumn 23, Issue 4, 2008, Pages 321-326

  Ozmenler, Nahit Kamil ^a   Karlidere, Tunay ^a   Bozkurt, Ali ^a   Yetkin, Sinan ^a   Doruk, Ali ^a   Sutcigil, Levent ^a   Cansever, Adnan ^a   Uzun, Ozcan ^a   Ozgen, Fuat ^a   Ozsahin, Aytekin ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Depression; Mirtazapine; Sexual dysfunction

Indexed keywords

MIRTAZAPINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; FEMALE; FOLLOW UP; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; OPEN STUDY; OUTPATIENT; PILOT STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; REMISSION; SCORING SYSTEM; SEXUAL DYSFUNCTION; SEXUAL SATISFACTION; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIANSERIN; MIDDLE AGED; PILOT PROJECTS; QUESTIONNAIRES; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 47249142970     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.929     Document Type: Article

References (29)

1. Akdemir A, Örsel S, Daǧ I, et al. 1996. Hamilton depresyon derecelendirme ölçeǧi (HDDÖ)'nin geçerliǧi, güvenirliǧi ve klinikte kullanimi. Psikiyatri Psikoloji Psikofarmakoloji Dergisi 4(4): 251-259.
2. Barkin RL, Chor PN, Braun BG, et al. 1999. A trilogy case review highlighting the clinical and pharmacologic applications of mirtazapine in reducing polypharmacy for anxiety, agitation, insomnia, depression, and sexual Dysfunction. Prim Care Companion J Clin Psychiatry 1(5): 142-145.
3. Bolling MY, Kohlenberg RJ. 2004. Reasons for quitting serotonin reuptake inhibitor therapy: paradoxical psychological side effects and patient satisfaction. Psychother Psychosom 73: 380-385.
4. Clayton AH, Croft HA, Horrigan JP, et al. 2006. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. J Clin Psychiatry 67(5): 736-746.
5. Clayton AH, Pradko JF, Croft HA, et al. 2002. Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 63: 357-366.
6. de la Gandara J, Aguera L, Rojo JE, et al. 2005. Use of antidepressant combinations: which, when and why? Results of a Spanish survey. Acta Psychiatr Scand Suppl 428: 32-36.
7. Gelenberg AJ, McGahuey C, Laukes C, et al. 2000. Mirtazapine substitution in SSRI-induced sexual dysfunction. J Clin Psychiatry 61(5): 356-360.
8. Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatr 23: 56-62.
9. Hamilton M. 2000. Hamilton rating scale for depression (Ham-D). In Handbook of Psychiatric Measures, Task force for the handbook of psychiatric measures (eds). American Psychiatric Association Press: Washington, DC; 526-529.
10. Hirschfeld RM. 1999. Care of the sexually active depressed patient. J Clin Psychiatry 60: 32-35.
11. Hirschfeld RM, Vornik LA. 2004. Newer antidepressants: review of efficacy and safety of escitalopram and duloxetine. J Clin Psychiatry 65 (suppl. 4): 46-52.
12. Hollander E, McCarley A. 1992. Yohimbine treatment of sexual side-effects induced by serotonin reuptake blockers. J Clin Psychiatry 53(6): 207-209.
13. Koutouvidis N, Pratikakis M, Fotiadou A. 1999. The use of mirtazapine in a group of 11 patients following poor compliance to selective serotonin reuptake inhibitor treatment due to sexual dysfunction. Int Clin Psychopharmacol 14(4): 253-255.
14. Landen M, Eriksson E, Agren H, et al. 1999. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 19(3): 268-271.
15. Landen M, Thase ME. 2006. A Model to Explain the Therapeutic Effects of Serotonin Reuptake Inhibitors: the role of 5-HT2 receptors. Psychopharmacol Bull 39(1): 147-166.
16. Masand PS, Ashton AK, Gupta S, et al. 2001. Sustained-release buproprion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled parallel-group study. Am J Psychiatry 158(5): 805-807.
17. Mendelson SD. 1992. Review and reevaluation of the role of serotonin in the modulation of lordosis behavior in the female rat. Neurosci Biobehav Rev 16(3): 309-350.
18. Michelson D, Kociban K, Tamura R, et al. 2002. Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake-associated female sexual dysfunction: a randomized, placebo controlled trial. J Psychiatr Res 36(3): 147-152.
19. Montejo AL, Llorca G, Izquierdo JA, et al. 2001. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish working group for the study of psychotropic-related sexual dysfunction. J Clin Psychiatry 62 (Suppl 3): 10-21.
20. Montgomery SA, Baldwin DS, Riley A. 2002. Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction. J Affect Disord 69(1-3): 119-140.
21. Munoz M, Bancroft J, Turner M. 1994. Evaluating the effects of an alpha-2 adrenoceptor antagonist on erectile function in the human male. 1. The erectile response to erotic stimuli in volunteers. Psychopharmacology 115(4): 463-470.
22. Nurnberg HG, Hensley PL, Lauriello J, et al. 1999. Sildenafil for women patients with antidepressant-induced sexual dysfunction. Psychiatr Serv 50(8): 1076-1078.
23. Rust J, Golombok S. 1986. The GRISS: a psychometric instrument for the assessment of sexual dysfunction. Arch Sex Behav 15(2): 157-165.
24. Saiz-Ruiz J, Montes JM, Ibanez A, et al. 2005. Assessment of sexual functioning in depressed patients treated with mirtazapine: a naturalistic 6-month study. Hum Psychopharmacol 20(6): 435-440.
25. Steffens DC, Krishnan KR, Helms MJ. 1997. Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis. Depress Anxiety 6(1): 10-18.
26. Stimmel GL, Dopheide JA, Stahl SM. 1997. Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects. Pharmacotherapy 17(1): 10-21.
27. Tuǧrul C, Öztan N, Kabakçi E. 1993. Golombok- Rust cinsel doyum ölçeǧinin standardizasyon čalişmasi. Türk Psikiyatri Derg 4(2): 83-88.
28. Werneke U, Northey S, Bhugra D. 2006. Antidepressants and sexual dysfunction. Acta Psychiatr Scand 114(6): 384-397.
29. Williams VS, Baldwin DS, Hogue SL, Fehnel SE, Hollis KA, Edin HM. 2006. Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey. J Clin Psychiatry 67(2): 204-210.